We now offer a free-of-charge iodine recycling service. We prevent iodine contrast media leftovers from being thrown in the sink and eliminate waste, with the aim to preserve the environment. Recycled iodine is extracted from the returned substance and used for production of GE Healthcare X-ray contrast media.
Learn more about our iodine recycling service.
Iodine is a limited resource and potential iodine shortages could affect contrast media production.1-3. Discover our commitment to securing iodine supply. Learn more
Iodine recycling is available in certain countries.
The value of +PLUSPAK™ packaging
We are the only company able to offer polypropylene bottles for our contrast media. An average radiology department loses 3.5 hours each month to injuries from broken contrast agent bottles and cuts from their sharp metal crimpings.4 With +PLUSPAK’s thoughtful packaging, designed to enhance safety and efficiency, these disruptions are entirely avoidable.
Discover how +PLUSPAK could help improve safety and efficiency in your radiology department.
Investing to meet procedural demand and provide a broad portfolio of products
To meet your demand, we have a broad portfolio of products across a wide variety of modalities covering X-ray/CT, MRI and Ultrasound and have invested over $240m in the past five years in our R&D, manufacturing and supply chain.5,6
Learn more about our contrast media capabilities and investment from GE Healthcare.
Please contact your local GE Healthcare contrast media representative for your local country full Summary of Product Characteristics (SPC) before prescribing. Further information available on request.
X-ray/CT: Omnipaque™ (iohexol)
Every second, 2 patients are imaged using Omnipaque around the world.7
Omnipaque is listed in the WHO (World Health Organization) essential drug list8 and has been used in over 800 million procedures.7
Omnipaque is indicated for intravenous, intra-arterial, body cavity, intrathecal and gastrointestinal studies.
Find out more
Please click here for the Omnipaque UK Prescribing Information
X-ray/CT: Visipaque™ (iodixanol)
Visipaque is a third-generation X-ray contrast agent with a unique molecular structure developed to further improve upon the toxicity profile of iodinated contrast agents.9,10 It is isosmolar to blood with the aim of counteracting major fluid shifts across membranes and limiting discomfort.9,11 It is also formulated with balanced electrolytes to help minimize effects on cardiac contractile force/fibrillatory propensity.9,11
While ‘low’ osmolar agents form the mainstay in the general population of patients undergoing X-ray/CT procedures, Visipaque may be preferred for any procedure that exposes the vulnerable patient to cardiovascular or renal insult.10,12
Find out more
Please click here for the Visipaque UK Prescribing Information
MRI: Clariscan™ (gadoteric acid)
Clariscan is a macrocyclic gadolinium-based contrast agent, introduced in Europe in 2017 and now approved in over 60 countries worldwide and used in more than 5 million patients.
As with all contrast media products from GE Healthcare, Active Pharmaceutical Ingredient for Clariscan is manufactured in Norway, with all stages of manufacturing and delivery managed entirely by GE Healthcare so you can be sure of its quality and reliable supply.13
Find out more
Please click here for the Clariscan UK Prescribing Information